Panacea Biotec Pharma Ltd. invested US$925,000 (~Rs.7.92 Crore) in its subsidiary Panacea Biotec Inc. on December 27, 2024, following a previous investment of US$75,000. This step aims to support the subsidiary's operations in the US healthcare market.